Intestinal permeability in colorectal cancer patients treated by raltitrexed or irinotecan

J Clin Gastroenterol. 2003 Aug;37(2):192-3. doi: 10.1097/00004836-200308000-00021.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / metabolism*
  • Female
  • Humans
  • Intestinal Mucosa / metabolism*
  • Irinotecan
  • Male
  • Middle Aged
  • Permeability
  • Quinazolines / therapeutic use*
  • Thiophenes / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Quinazolines
  • Thiophenes
  • Irinotecan
  • raltitrexed
  • Camptothecin